|
1.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3.
|
Naito S, Tomita Y, Rha SY, et al: Kidney
Cancer Working Group report. Jpn J Clin Oncol. 40(Suppl 1):
i51–i56. 2010. View Article : Google Scholar
|
|
4.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
5.
|
Chow WH, Devesa SS, Warren JL and Fraumeni
JF Jr: Rising incidence of renal cell cancer in the United States.
JAMA. 281:1628–1631. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hock LM, Lynch J and Balaji KC: Increasing
incidence of all stages of kidney cancer in the last 2 decades in
the United States: An analysis of Surveillance, Epidemiology and
End Results program data. J Urol. 167:57–60. 2002. View Article : Google Scholar
|
|
7.
|
Lindblad P: Epidemiology of renal cell
carcinoma. Scand J Surg. 93:88–96. 2004.
|
|
8.
|
Murai M and Oya M: Renal cell carcinoma:
etiology, incidence and epidemiology. Curr Opin Urol. 14:229–233.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Motzer RJ, Agarwal N, Beard C, et al: NCCN
clinical practice guidelines in oncology: kidney cancer. J Natl
Compr Canc Netw. 7:618–630. 2009.PubMed/NCBI
|
|
10.
|
Ljungberg B, Cowan NC, Hanbury DC, et al:
EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol.
58:398–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Escudier B, Eisen T, Porta C, et al: Renal
cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 23(Suppl 7): vii65–vii71. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Lam JS, Leppert JT, Belldegrun AS and
Figlin RA: Novel approaches in the therapy of metastatic renal cell
carcinoma. World J Urol. 23:202–212. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010.
|
|
14.
|
Molina AM and Motzer RJ: Current
algorithms and prognostic factors in the treatment of metastatic
renal cell carcinoma. Clin Genitourin Cancer. 6(Suppl 1): S7–S13.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ono K, Tanaka T, Tsunoda T, et al:
Identification by cDNA microarray of genes involved in ovarian
carcinogenesis. Cancer Res. 60:5007–5011. 2000.PubMed/NCBI
|
|
16.
|
Hirota E, Yan L, Tsunoda T, et al:
Genome-wide gene expression profiles of clear cell renal cell
carcinoma: Identification of molecular targets for treatment of
renal cell carcinoma. Int J Oncol. 29:799–827. 2006.PubMed/NCBI
|
|
17.
|
Saito-Hisaminato A, Katagiri T, Kakiuchi
S, Nakamura T, Tsunoda T and Nakamura Y: Genome-wide profiling of
gene expression in 29 normal human tissues with a cDNA microarray.
DNA Res. 9:35–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Oda K, Arakawa H, Tanaka T, et al:
p53AIP1, a potential mediator of p53-dependent apoptosis, and its
regulation by Ser-46-phosphorylated p53. Cell. 102:849–862. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Matsuda K, Yoshida K, Taya Y, Nakamura K,
Nakamura Y and Arakawa H: p53AIP1 regulates the mitochondrial
apoptotic pathway. Cancer Res. 62:2883–2889. 2002.PubMed/NCBI
|
|
20.
|
Tanikawa C, Ueda K, Nakagawa H, Yoshida N,
Nakamura Y and Matsuda K: Regulation of Protein Citrullination
through p53/PAD14 Network in DNA Damage Response. Cancer Res.
69:8761–8769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tanikawa C, Matsuda K, Fukuda S, Nakamura
Y and Arakawa H: p53RDL1 regulates p53-dependent apoptosis. Nat
Cell Biol. 5:216–223. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Watanabe G, Kato S, Nakata H, Ishida T,
Ohuchi N and Ishioka C: alphaB-crystallin: a novel p53-target gene
required for p53-dependent apoptosis. Cancer Sci. 100:2368–2375.
2009. View Article : Google Scholar
|
|
23.
|
Evans JR, Bosman JD, Brown-Endres L,
Yehiely F and Cryns VL: Induction of the small heat shock protein
alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
Breast Cancer Res Treat. 122:159–168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Krief S, Faivre JF, Robert P, et al:
Identification and characterization of cvHsp. A novel human small
stress protein selectively expressed in cardiovascular and
insulin-sensitive tissues. J Biol Chem. 274:36592–36600. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Sun X, Fontaine JM, Rest JS, Shelden EA,
Welsh MJ and Benndorf R: Interaction of human HSP22 (HSPB8) with
other small heat shock proteins. J Biol Chem. 279:2394–2402. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Vos MJ, Zijlstra MP, Kanon B, et al: HSPB7
is the most potent polyQ aggregation suppressor within the HSPB
family of molecular chaperones. Hum Mol Genet. 19:4677–4693. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Cappola TP, Li M, He J, et al: Common
variants in HSPB7 and FRMD4B associated with advanced heart
failure. Circ Cardiovasc Genet. 3:147–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Matkovich SJ, Van Booven DJ, Hindes A, et
al: Cardiac signaling genes exhibit unexpected sequence diversity
in sporadic cardiomyopathy, revealing HSPB7 polymorphisms
associated with disease. J Clin Invest. 120:280–289. 2010.
View Article : Google Scholar
|
|
29.
|
Stark K, Esslinger UB and Reinhard W:
Genetic association study identifies HSPB7 as a risk gene for
idiopathic dilated cardiomyopathy. PLoS Genet. 6:e10011672010.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Villard E, Perret C, Gary F, et al: A
genome-wide association study identifies two loci associated with
heart failure due to dilated cardiomyopathy. Eur Heart J.
32:1065–1076. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Li XP, Luo R and Hua W and Hua W:
Polymorphisms of Hspb7 gene associate with idiopathic dilated
cardiomyopathy susceptibility in a Chinese population. Heart.
98:E47. 2012. View Article : Google Scholar
|
|
32.
|
Rosenfeld GE, Mercer EJ, Mason CE and
Evans T: Small heat shock proteins Hspb7 and Hspb12 regulate early
steps of cardiac morphogenesis. Dev Biol. 381:389–400. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Huang Z, Cheng Y, Chiu PM, et al: Tumor
suppressor Alpha B-crystallin (CRYAB) associates with the
cadherin/catenin adherens junction and impairs NPC
progression-associated properties. Oncogene. 31:3709–3720. 2012.
View Article : Google Scholar
|
|
34.
|
Ragnarsson G, Eiriksdottir G,
Johannsdottir JT, Jonasson JG, Egilsson V and Ingvarsson S: Loss of
heterozygosity at chromosome 1p in different solid human tumours:
association with survival. Br J Cancer. 79:1468–1474. 1999.
View Article : Google Scholar : PubMed/NCBI
|
